Cargando…
Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy
Background: Hematologic toxicity is a critical problem limiting treatment delivery in cancer patients undergoing concurrent chemoradiotherapy. However, the extent to which anatomic variations in radiation dose limit chemotherapy delivery is poorly understood. A unique natural experiment arises in pa...
Autores principales: | Vitzthum, Lucas K., Heide, Elena S., Park, Helen, Williamson, Casey W., Sheridan, Paige, Huynh-Le, Minh-Phuong, Sirak, Igor, Wei, Lichun, Tarnawski, Rafal, Mahantshetty, Umesh, Nguyen, Cammie, Mayadev, Jyoti, Yashar, Catheryn M., Sacco, Assuntina G., Mell, Loren K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385402/ https://www.ncbi.nlm.nih.gov/pubmed/32793487 http://dx.doi.org/10.3389/fonc.2020.01179 |
Ejemplares similares
-
Global challenges of radiotherapy for the treatment of locally advanced cervical cancer
por: Mayadev, Jyoti S, et al.
Publicado: (2022) -
The role of p16 as a biomarker in nonoropharyngeal head and neck cancer
por: Vitzthum, Lucas K., et al.
Publicado: (2018) -
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study
por: Mayadev, Jyoti, et al.
Publicado: (2020) -
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
por: Sacco, Assuntina G, et al.
Publicado: (2016) -
SMARCA4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT—Case Report
por: Sirák, Igor, et al.
Publicado: (2021)